These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32547111)

  • 21. An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu
    Marth K; Renner A; Langmayr G; Pohl W; Nguyen DT; Kuhl HC
    Drugs Real World Outcomes; 2024 Jun; 11(2):231-240. PubMed ID: 38351402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines.
    Harrow B; Sedaghat AR; Caldwell-Tarr A; Dufour R
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1426-1436. PubMed ID: 27882840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.
    Klimek L; Demoly P; Price D
    Expert Rev Clin Pharmacol; 2016; 9(5):705-14. PubMed ID: 26839083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of MP-AzeFlu compared to monotherapy on COX-2, PGE
    Vicens-Artes S; Roca-Ferrer J; Tubita V; Fuentes M; Alobid I; Valero A; Kopietz F; Nguyen D; Mullol J
    Immun Inflamm Dis; 2023 Jan; 11(1):e709. PubMed ID: 36705401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study.
    Klimek L; Price D; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J
    Int Arch Allergy Immunol; 2020; 181(10):754-764. PubMed ID: 32829329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu.
    Dollner R; Lorentz Larsen P; Dheyauldeen S; Steinsvåg S
    Allergy Rhinol (Providence); 2017 Oct; 8(3):148-156. PubMed ID: 29070272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care.
    De Jong HJI; Voorham J; Scadding GK; Bachert C; Canonica GW; Smith P; Wahn U; Ryan D; Castillo JA; Carter VA; Murray RB; Price DB
    World Allergy Organ J; 2020 Dec; 13(12):100490. PubMed ID: 33376573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management.
    Bachert C; Bousquet J; Hellings P
    Clin Transl Allergy; 2018; 8():25. PubMed ID: 29983907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal immune gene expression in response to azelastine and fluticasone propionate combination or monotherapy.
    Watts AM; West NP; Smith PK; Zhang P; Cripps AW; Cox AJ
    Immun Inflamm Dis; 2022 Mar; 10(3):e571. PubMed ID: 34813682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers.
    Qi W; Liu Y; Xue W; Li K; Gorski JC; Liu M; Yan T; Nguyen DT; Ramalingam RK
    J Asthma Allergy; 2023; 16():667-677. PubMed ID: 37409000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of MP-AzeFlu enhanced by activation of bitter taste receptor TAS2R.
    Ekstedt S; Kumlien Georén S; Cardell LO
    Allergy Asthma Clin Immunol; 2020; 16():45. PubMed ID: 32514276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
    Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Romania.
    Agache I; Doros IC; Leru PM; Bucur I; Poenaru M; Sarafoleanu C
    Rhinology; 2018 Mar; 56(1):33-41. PubMed ID: 28942457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction: A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
    Zhou B; Cheng L; Pan J; Wang H; Jin Y; Zhao C; Lin P; Tan G; Fang H; Zhang H; Zhou H; Dong Y; Kuhl HC; Ramalingam RK; Nguyen DT
    Pulm Ther; 2024 Mar; 10(1):143-144. PubMed ID: 38099987
    [No Abstract]   [Full Text] [Related]  

  • 35. Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.
    Klimek L; Mullol J; Hellings P; Gevaert P; Mösges R; Fokkens W
    Expert Opin Pharmacother; 2016; 17(5):657-69. PubMed ID: 26800187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
    Meltzer EO; Stahlman JE; Leflein J; Meltzer S; Lim J; Dalal AA; Prillaman BA; Philpot EE
    Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics.
    Di Lorenzo G; Gervasi F; Drago A; Esposito Pellitteri M; Di Salvo A; Cosentino D; Potestio M; Colombo A; Candore G; Mansueto S; Caruso C
    Clin Exp Allergy; 1999 Oct; 29(10):1367-77. PubMed ID: 10520057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal Azelastine and Fluticasone as Combination Therapy for Allergic Rhinitis: Systematic Review and Meta-analysis.
    Debbaneh PM; Bareiss AK; Wise SK; McCoul ED
    Otolaryngol Head Neck Surg; 2019 Sep; 161(3):412-418. PubMed ID: 30961435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.
    Berger W; Sher E; Gawchik S; Fineman S
    Allergy Asthma Proc; 2018 Mar; 39(2):110-116. PubMed ID: 29490769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.